Global Stomach Cancer and Gastric Cancer Drugs Market Growth (Status and Outlook) 2020-2025

  • receipt Report ID : 59913
  • calendar_today Published On: May, 2020
  • file_copy Pages: 117
  • list Pharmaceuticals and Healthcare
Buy @ $3660

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Stomach Cancer and Gastric Cancer Drugs will have significant change from previous year. By the most conservative estimates of global Stomach Cancer and Gastric Cancer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Stomach Cancer and Gastric Cancer Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Stomach Cancer and Gastric Cancer Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Stomach Cancer and Gastric Cancer Drugs, covering the supply chain analysis, impact assessment to the Stomach Cancer and Gastric Cancer Drugs market size growth rate in several scenarios, and the measures to be undertaken by Stomach Cancer and Gastric Cancer Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

Programmed Cell Death Protein 1 (PD-1) Inhibitors

Human Epidermal Growth Factor Receptor (HER2) Antagonists

Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

Hospitals

Clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Ipsen Pharma

Jiangsu Hengrui Medicine Co., Ltd.

Merck & Co., Inc.

Eli Lilly

Roche

Bristol-Myers Squibb Company

Celltrion Inc.

Novartis AG

TAIHO PHARMACEUTICAL CO., LTD.

Bayer AG

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Stomach Cancer and Gastric Cancer Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Stomach Cancer and Gastric Cancer Drugs market by identifying its various subsegments.

Focuses on the key global Stomach Cancer and Gastric Cancer Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Stomach Cancer and Gastric Cancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Stomach Cancer and Gastric Cancer Drugs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

1.7 What is the Impact of Covid-19 Outbreak On the Stomach Cancer and Gastric Cancer Drugs?

1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.

1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.

1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Stomach Cancer and Gastric Cancer Drugs Market Size in 2020, by Scenario

1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size 2015-2025

2.1.2 Stomach Cancer and Gastric Cancer Drugs Market Size CAGR by Region

2.2 Stomach Cancer and Gastric Cancer Drugs Segment by Type

2.2.1 Programmed Cell Death Protein 1 (PD-1) Inhibitors

2.2.2 Programmed Cell Death Protein 1 (PD-1) Inhibitors

2.2.3 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists

2.2.4 Others

2.3 Stomach Cancer and Gastric Cancer Drugs Market Size by Type

2.3.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2015-2020)

2.3.2 Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Type (2015-2020)

2.4 Stomach Cancer and Gastric Cancer Drugs Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.5 Stomach Cancer and Gastric Cancer Drugs Market Size by Application

2.5.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application (2015-2020)

2.5.2 Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Application (2015-2020)

3 Global Stomach Cancer and Gastric Cancer Drugs by Players

3.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Players

3.1.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size by Players (2018-2020)

3.1.2 Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Players (2018-2020)

3.2 Global Stomach Cancer and Gastric Cancer Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Stomach Cancer and Gastric Cancer Drugs by Regions

4.1 Stomach Cancer and Gastric Cancer Drugs Market Size by Regions

4.2 Americas Stomach Cancer and Gastric Cancer Drugs Market Size Growth

4.3 APAC Stomach Cancer and Gastric Cancer Drugs Market Size Growth

4.4 Europe Stomach Cancer and Gastric Cancer Drugs Market Size Growth

4.5 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size Growth

5 Americas

5.1 Americas Stomach Cancer and Gastric Cancer Drugs Market Size by Countries

5.2 Americas Stomach Cancer and Gastric Cancer Drugs Market Size by Type

5.3 Americas Stomach Cancer and Gastric Cancer Drugs Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Stomach Cancer and Gastric Cancer Drugs Market Size by Regions

6.2 APAC Stomach Cancer and Gastric Cancer Drugs Market Size by Type

6.3 APAC Stomach Cancer and Gastric Cancer Drugs Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Stomach Cancer and Gastric Cancer Drugs by Countries

7.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type

7.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs by Countries

8.2 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Type

8.3 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Stomach Cancer and Gastric Cancer Drugs Market Forecast

10.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast (2021-2025)

10.2 Global Stomach Cancer and Gastric Cancer Drugs Forecast by Regions

10.2.1 Global Stomach Cancer and Gastric Cancer Drugs Forecast by Regions (2021-2025)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Stomach Cancer and Gastric Cancer Drugs Forecast by Type

10.8 Global Stomach Cancer and Gastric Cancer Drugs Forecast by Application

11 Key Players Analysis

11.1 Ipsen Pharma

11.1.1 Company Details

11.1.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.1.4 Main Business Overview

11.1.5 Ipsen Pharma News

11.2 Jiangsu Hengrui Medicine Co., Ltd.

11.2.1 Company Details

11.2.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.2.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.2.4 Main Business Overview

11.2.5 Jiangsu Hengrui Medicine Co., Ltd. News

11.3 Merck & Co., Inc.

11.3.1 Company Details

11.3.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.3.3 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.3.4 Main Business Overview

11.3.5 Merck & Co., Inc. News

11.4 Eli Lilly

11.4.1 Company Details

11.4.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.4.4 Main Business Overview

11.4.5 Eli Lilly News

11.5 Roche

11.5.1 Company Details

11.5.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.5.3 Roche Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.5.4 Main Business Overview

11.5.5 Roche News

11.6 Bristol-Myers Squibb Company

11.6.1 Company Details

11.6.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.6.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.6.4 Main Business Overview

11.6.5 Bristol-Myers Squibb Company News

11.7 Celltrion Inc.

11.7.1 Company Details

11.7.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.7.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.7.4 Main Business Overview

11.7.5 Celltrion Inc. News

11.8 Novartis AG

11.8.1 Company Details

11.8.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.8.3 Novartis AG Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.8.4 Main Business Overview

11.8.5 Novartis AG News

11.9 TAIHO PHARMACEUTICAL CO., LTD.

11.9.1 Company Details

11.9.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.9.4 Main Business Overview

11.9.5 TAIHO PHARMACEUTICAL CO., LTD. News

11.10 Bayer AG

11.10.1 Company Details

11.10.2 Stomach Cancer and Gastric Cancer Drugs Product Offered

11.10.3 Bayer AG Stomach Cancer and Gastric Cancer Drugs Revenue, Gross Margin and Market Share (2018-2020)

11.10.4 Main Business Overview

11.10.5 Bayer AG News

12 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Stomach Cancer and Gastric Cancer Drugs Market Size in 2020, by Scenario

Table 2. COVID-19: Measures to be Undertaken by Stomach Cancer and Gastric Cancer Drugs Companies

Table 3. Research Methodology

Table 4. Data Source

Table 5. Stomach Cancer and Gastric Cancer Drugs Market Size CAGR by Region 2015-2025 ($ Millions)

Table 6. Major Players of Programmed Cell Death Protein 1 (PD-1) Inhibitors

Table 7. Major Players of Human Epidermal Growth Factor Receptor (HER2) Antagonists

Table 8. Major Players of Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists

Table 9. Major Players of Others

Table 10. Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2014-2019) ($ Millions)

Table 11. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2015-2020)

Table 12. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2015-2020) ($ Millions)

Table 13. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application (2015-2020)

Table 14. Global Stomach Cancer and Gastric Cancer Drugs Revenue by Players (2018-2020) ($ Millions)

Table 15. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Players (2018-2020)

Table 16. Global Stomach Cancer and Gastric Cancer Drugs Key Players Head office and Products Offered

Table 17. Stomach Cancer and Gastric Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Regions 2015-2020 ($ Millions)

Table 21. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Regions 2015-2020

Table 22. Americas Stomach Cancer and Gastric Cancer Drugs Market Size by Countries (2015-2020) ($ Millions)

Table 23. Americas Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Countries (2015-2020)

Table 24. Americas Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2015-2020) ($ Millions)

Table 25. Americas Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2015-2020)

Table 26. Americas Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2015-2020) ($ Millions)

Table 27. Americas Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application (2015-2020)

Table 28. APAC Stomach Cancer and Gastric Cancer Drugs Market Size by Regions (2015-2020) ($ Millions)

Table 29. APAC Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Regions (2015-2020)

Table 30. APAC Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2015-2020) ($ Millions)

Table 31. APAC Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2015-2020)

Table 32. APAC Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2015-2020) ($ Millions)

Table 33. APAC Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application (2015-2020)

Table 34. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Countries (2015-2020) ($ Millions)

Table 35. Europe Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Countries (2015-2020)

Table 36. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2015-2020) ($ Millions)

Table 37. Europe Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2015-2020)

Table 38. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2015-2020) ($ Millions)

Table 39. Europe Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application (2015-2020)

Table 40. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Countries (2015-2020) ($ Millions)

Table 41. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Countries (2015-2020)

Table 42. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2015-2020) ($ Millions)

Table 43. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2015-2020)

Table 44. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2015-2020) ($ Millions)

Table 45. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application (2015-2020)

Table 46. Key and Potential Regions of Stomach Cancer and Gastric Cancer Drugs

Table 47. Key Application and Potential Industries of Stomach Cancer and Gastric Cancer Drugs

Table 48. Key Challenges of Stomach Cancer and Gastric Cancer Drugs

Table 49. Key Trends of Stomach Cancer and Gastric Cancer Drugs

Table 50. Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)

Table 51. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share Forecast by Regions

Table 52. Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Type (2021-2025) ($ Millions)

Table 53. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share Forecast by Type (2021-2025)

Table 54. Global Stomach Cancer and Gastric Cancer Drugs Market Size Forecast by Application (2021-2025) ($ Millions)

Table 55. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share Forecast by Application (2021-2025)

Table 56. Ipsen Pharma Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 57. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 58. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 59. Ipsen Pharma Main Business

Table 60. Ipsen Pharma Latest Developments

Table 61. Jiangsu Hengrui Medicine Co., Ltd. Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 62. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 63. Jiangsu Hengrui Medicine Co., Ltd. Main Business

Table 64. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 65. Jiangsu Hengrui Medicine Co., Ltd. Latest Developments

Table 66. Merck & Co., Inc. Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 67. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 68. Merck & Co., Inc. Main Business

Table 69. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 70. Merck & Co., Inc. Latest Developments

Table 71. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 72. Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 73. Eli Lilly Main Business

Table 74. Eli Lilly Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 75. Eli Lilly Latest Developments

Table 76. Roche Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 77. Roche Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 78. Roche Main Business

Table 79. Roche Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 80. Roche Latest Developments

Table 81. Bristol-Myers Squibb Company Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 82. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 83. Bristol-Myers Squibb Company Main Business

Table 84. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 85. Bristol-Myers Squibb Company Latest Developments

Table 86. Celltrion Inc. Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 87. Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 88. Celltrion Inc. Main Business

Table 89. Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 90. Celltrion Inc. Latest Developments

Table 91. Novartis AG Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 92. Novartis AG Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 93. Novartis AG Main Business

Table 94. Novartis AG Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 95. Novartis AG Latest Developments

Table 96. TAIHO PHARMACEUTICAL CO., LTD. Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 97. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 98. TAIHO PHARMACEUTICAL CO., LTD. Main Business

Table 99. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 100. TAIHO PHARMACEUTICAL CO., LTD. Latest Developments

Table 101. Bayer AG Details, Company Total Revenue (in $ million), Head Office, Stomach Cancer and Gastric Cancer Drugs Major Market Areas and Its Competitors

Table 102. Bayer AG Stomach Cancer and Gastric Cancer Drugs Product Offered

Table 103. Bayer AG Main Business

Table 104. Bayer AG Stomach Cancer and Gastric Cancer Drugs Revenue and Gross Margin (2018-2020E)

Table 105. Bayer AG Latest Developments

List of Figures

Figure 1. Stomach Cancer and Gastric Cancer Drugs Report Years Considered

Figure 2. Market Research Methodology

Figure 3. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate 2015-2025 ($ Millions)

Figure 4. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type (2015-2020)

Figure 5. Global Programmed Cell Death Protein 1 (PD-1) Inhibitors Market Size Growth Rate

Figure 6. Global Human Epidermal Growth Factor Receptor (HER2) Antagonists Market Size Growth Rate

Figure 7. Global Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Market Size Growth Rate

Figure 8. Global Others Market Size Growth Rate

Figure 9. Stomach Cancer and Gastric Cancer Drugs in Hospitals

Figure 10. Global Stomach Cancer and Gastric Cancer Drugs Market: Hospitals (2015-2020) ($ Millions)

Figure 11. Stomach Cancer and Gastric Cancer Drugs in Clinics

Figure 12. Global Stomach Cancer and Gastric Cancer Drugs Market: Clinics (2015-2020) ($ Millions)

Figure 13. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application in 2019

Figure 14. Global Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Regions 2015-2020

Figure 15. Americas Stomach Cancer and Gastric Cancer Drugs Market Size 2015-2020 ($ Millions)

Figure 16. APAC Stomach Cancer and Gastric Cancer Drugs Market Size 2015-2020 ($ Millions)

Figure 17. Europe Stomach Cancer and Gastric Cancer Drugs Market Size 2015-2020 ($ Millions)

Figure 18. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size 2015-2020 ($ Millions)

Figure 19. Americas Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Countries in 2019

Figure 20. Americas Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type in 2019

Figure 21. Americas Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application in 2019

Figure 22. United States Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 23. Canada Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 24. Mexico Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 25. APAC Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Regions in 2019

Figure 26. APAC Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type in 2019

Figure 27. APAC Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application in 2019

Figure 28. China Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 29. Japan Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 30. Korea Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 31. Southeast Asia Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 32. India Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 33. Australia Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 34. Europe Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Countries in 2019

Figure 35. Europe Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type in 2019

Figure 36. Europe Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application in 2019

Figure 37. Germany Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 38. France Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 39. UK Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 40. Italy Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 41. Russia Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 42. Spain Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 43. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Countries in 2019

Figure 44. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Type in 2019

Figure 45. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size Market Share by Application in 2019

Figure 46. Egypt Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 47. South Africa Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 48. Israel Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 49. Turkey Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 50. GCC Countries Stomach Cancer and Gastric Cancer Drugs Market Size Growth 2015-2020 ($ Millions)

Figure 51. Global Stomach Cancer and Gastric Cancer Drugs arket Size Forecast (2021-2025) ($ Millions)

Figure 52. Americas Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 53. APAC Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 54. Europe Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 55. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 56. United States Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 57. Canada Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 58. Mexico Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 59. Brazil Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 60. China Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 61. Japan Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 62. Korea Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 63. Southeast Asia Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 64. India Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 65. Australia Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 66. Germany Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 67. France Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 68. UK Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 69. Italy Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 70. Russia Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 71. Spain Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 72. Egypt Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 73. South Africa Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 74. Israel Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 75. Turkey Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)

Figure 76. GCC Countries Stomach Cancer and Gastric Cancer Drugs Market Size 2021-2025 ($ Millions)